Yucui Dong

600 total citations
28 papers, 415 citations indexed

About

Yucui Dong is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Yucui Dong has authored 28 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Cancer Research and 6 papers in Genetics. Recurrent topics in Yucui Dong's work include Glioma Diagnosis and Treatment (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Genomics and Phylogenetic Studies (3 papers). Yucui Dong is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Genomics and Phylogenetic Studies (3 papers). Yucui Dong collaborates with scholars based in China, United States and Hong Kong. Yucui Dong's co-authors include Huan Ren, Jun Su, Huanyu Ju, Baixiang Li, Yan Wang, Shuying Gao, Ping Zhang, Yurui Zhang, Xuehua Zhang and Xiao Zhu and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Annals of Internal Medicine.

In The Last Decade

Yucui Dong

25 papers receiving 402 citations

Peers

Countries citing papers authored by Yucui Dong

Since Specialization

Citations

This map shows the geographic impact of Yucui Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yucui Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yucui Dong more than expected).

Fields of papers citing papers by Yucui Dong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yucui Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yucui Dong. The network helps show where Yucui Dong may publish in the future.

Co-authorship network of co-authors of Yucui Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Yucui Dong. A scholar is included among the top collaborators of Yucui Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yucui Dong. Yucui Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lysosomes finely control macrophage inflammatory function via regulating the release of lysosomal Fe2+ through TRPML1 channel 2025 ·Nature Communications ·Yanhong Xing, Mengmeng Wang, Feifei Zhang, (unknown), Xinyan Wang, Rong Chen, Zhongheng Sui, Yucui Dong, Dongxue Xu, (unknown), (unknown), (unknown), Weijie Cai, Meiqin Hu, Yuqing Wang, Jun‐Li Cao, Derong Cui, Jiansong Qi, Wuyang Wang	10
2	Multifunctional piezoelectric hydrogels under ultrasound stimulation boost chondrogenesis by recruiting autologous stem cells and activating the Ca2+/CaM/CaN signaling pathway 2025 ·Bioactive Materials ·Yubao Liu, Xu Liu, Xiaofei Li, (unknown), Hailong Wang, Yucui Dong, Feng Zhang, Yan Liu, Haoyang Liu, Ming-liang Ji, Lan Li, Qing Jiang, Jun Lu	2
3	Paris saponin VII restrains PD-L1 mediated immune evasion through the AKT1 and STAT3 signaling pathways 2025 ·Chemico-Biological Interactions ·Yudi Wang, (unknown), Yurui Zhang, Yitong Li, (unknown), Li Tong, Xiao Zhu, Jianyong Wang, Yucui Dong	0
4	Bidirectional regulation of the cGAS-STING pathway in the immunosuppressive tumor microenvironment and its association with immunotherapy 2024 ·Frontiers in Immunology ·Yurui Zhang, Yudi Wang, (unknown), Xiao Zhu, Yucui Dong	7
5	Prediction of acute myeloid leukemia prognosis based on autophagy features and characterization of its immune microenvironment 2024 ·Frontiers in Immunology ·(unknown), (unknown), Li Tong, (unknown), Fei Wang, (unknown), Yucui Dong, Xiao Zhu	3
6	A comparative analysis of TCR immune repertoire in COVID-19 patients 2024 ·Human Immunology ·Xiao Zhu, Enze Ma, (unknown), (unknown), (unknown), Fei Wang, (unknown), (unknown), Yucui Dong, Qinghua Jiang	0
7	IGFBP3 induces PD-L1 expression to promote glioblastoma immune evasion 2024 ·Cancer Cell International ·(unknown), Yudi Wang, (unknown), Xuehua Zhang, Ruomei Qi, Yurui Zhang, He Zhang, Xiao Zhu, Zhou-Yan Dong, Yucui Dong	4
8	The role of IGFBP-3 in tumor development and progression: enlightenment for diagnosis and treatment 2024 ·Medical Oncology ·Yudi Wang, (unknown), Xuehua Zhang, (unknown), Leilei Zhao, Ruomei Qi, Yurui Zhang, Xiao Li Zhu, Yucui Dong	0
9	5-Demethylnobiletin mediates cell cycle arrest and apoptosis via the ERK1/2/AKT/STAT3 signaling pathways in glioblastoma cells 2023 ·Frontiers in Oncology ·Xuehua Zhang, (unknown), Jin‐Long Xiao, Yudi Wang, Yunmeng Li, (unknown), He Zhang, Yurui Zhang, Xiao Zhu, Yucui Dong	4
10	IGFBP3 induced by the TGF-β/EGFRvIII transactivation contributes to the malignant phenotype of glioblastoma 2023 ·iScience ·Xuehua Zhang, Guoyan Wang, (unknown), (unknown), Ping Song, He Zhang, Yurui Zhang, Huanyu Ju, Xiaoyu Wang, Bin Wang, Huan Ren, Xiao Zhu, Yucui Dong	7
11	Bellidifolin ameliorates isoprenaline-induced cardiac hypertrophy by the Nox4/ROS signalling pathway through inhibiting BRD4 2023 ·Cell Death Discovery ·(unknown), Weizhe Liu, Juanjuan Zhang, Yucui Dong, (unknown), Yu Zhang, (unknown), Tingting Zhang, (unknown), Yue Zhang, Aiying Li	10
12	Overview of structural variation calling: Simulation, identification, and visualization 2022 ·Computers in Biology and Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), Lanlan Li, (unknown), Anastasia A. Anashkina, Qinghua Jiang, Yucui Dong, Xiao Zhu	6
13	Genome sequence assembly algorithms and misassembly identification methods 2022 ·Molecular Biology Reports ·(unknown), (unknown), (unknown), Yuxuan Liu, Enze Ma, Yunhong Ding, (unknown), (unknown), Yucui Dong, Xiao Zhu	5
14	The immunosuppressive microenvironment and immunotherapy in human glioblastoma 2022 ·Frontiers in Immunology ·Xuehua Zhang, (unknown), He Zhang, Yurui Zhang, Huanyu Ju, Xiaoyu Wang, Huan Ren, Xiao Zhu, Yucui Dong	41
15	DNA methylation-mediated caspase-8 downregulation is associated with anti-apoptotic activity and human malignant glioma grade 2017 ·International Journal of Molecular Medicine ·(unknown), Yucui Dong, Zhaoyu Liu, Yan Zou, Hui Xie, Yu Zhao, Jun Su, Fenglin Cao, Hua Jin, Huan Ren	12
16	misFinder: identify mis-assemblies in an unbiased manner using reference and paired-end reads 2015 ·BMC Bioinformatics ·Xiao Zhu, Henry C. M. Leung, Rongjie Wang, Francis Y. L. Chin, Siu Ming Yiu, (unknown), (unknown), Rui Zhang, Qinghua Jiang, Bo Liu, Yucui Dong, Guohui Zhou, Yadong Wang	13
17	Long-term exposure to imatinib reduced cancer stem cell ability through induction of cell differentiation via activation of MAPK signaling in glioblastoma cells 2012 ·Molecular and Cellular Biochemistry ·Yucui Dong, (unknown), Yan Zou, (unknown), Xinliang Lu, (unknown), Weihua Zhang, Hua Jin, Jun Su, Tao Jiang, Huan Ren	35
18	Differential Effect of Imatinib and Synergism of Combination Treatment with Chemotherapeutic Agents in Malignant Glioma Cells 2009 ·Basic & Clinical Pharmacology & Toxicology ·Huan Ren, (unknown), Yucui Dong, Alf Giese, Ting‐Chao Chou, Nikolai G. Rainov, Baofeng Yang	25
19	Epidermal Growth Factor Receptor as therapeutic targets in malignant glioma 2008 ·Yucui Dong, (unknown), Huan Ren	1
20	Subacute Oral Exposure to Dibromoacetic Acid Induced Immunotoxicity and Apoptosis in the Spleen and Thymus of the mice 2008 ·Toxicological Sciences ·Shuying Gao, Yan Wang, Ping Zhang, Yucui Dong, Baixiang Li	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact